Spruce Biosciences
Clinical trials sponsored by Spruce Biosciences, explained in plain language.
-
PCOS drug trial halted: tildacerfont fails to show promise
Disease control TerminatedThis study tested a drug called tildacerfont in 27 women with PCOS who had high levels of adrenal androgens. The goal was to see if the drug could safely lower these hormone levels. The trial was terminated early, so results are limited.
Phase: PHASE2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
New hope for kids with rare hormone disorder: drug may cut steroid doses
Disease control TerminatedThis study tested a drug called tildacerfont in 67 children aged 2 to 17 with congenital adrenal hyperplasia (CAH), a condition where the body can't make certain hormones properly. The goal was to see if the drug is safe and can help control the disease while reducing the need fo…
Phase: PHASE2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Hope for CAH patients: can tildacerfont cut steroid needs?
Disease control TerminatedThis study tested a drug called Tildacerfont in 100 adults with classic congenital adrenal hyperplasia (CAH), a condition where the body can't make certain hormones properly. The goal was to see if it could safely reduce the high doses of steroids patients need to take. The study…
Phase: PHASE2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated May 22, 2026 13:51 UTC